Tyzeka

Indicated For

chronic hepatitis B

About This Medication

# Novartis Patient Assistance Foundation Patient Guide: How to Get Tyzeka (Telbivudine) at Low or No Cost ## About This Program The Novartis Patient Assistance Foundation offers free or reduced-cost Tyzeka (telbivudine) to eligible patients who cannot afford their medication. Tyzeka is an FDA-approved antiviral medication used to treat chronic hepatitis B in adults with evidence of viral replication and either elevated liver enzymes or active liver disease.[2][4] ## About Tyzeka (Telbivudine) Tyzeka is a nucleoside reverse transcriptase inhibitor that works by slowing the reproduction of hepatitis B virus in your body.[2][4] The standard adult dose is 600 mg taken once daily by mouth, with or without food.[2] Your doctor may adjust your dose if you have kidney problems.[2] Common side effects may include fatigue, headache, and abdominal pain. More serious but rare side effects include muscle pain or weakness (myopathy), nerve problems (peripheral neuropathy), and liver problems.[6] It is important to take this medication exactly as prescribed and attend all follow-up appointments with your healthcare provider. ## Who Qualifies While specific income thresholds are not publicly detailed in available program materials, the Novartis Patient Assistance Foundation generally serves patients who: - Have been prescribed Tyzeka by a licensed healthcare provider - Meet financial eligibility criteria (typically based on household income and family size) - Are U.S. residents - May or may not have insurance coverage Your doctor can help determine if you meet the program's eligibility requirements during the application process. ## How to Apply ### Step 1: Gather Required Documents Before starting your application, collect the following: - Completed enrollment application form (provided by your doctor or available by calling the program) - Proof of income (recent tax returns, pay stubs, or benefit statements) - Proof of household size (birth certificates, marriage certificate, or household documentation) - Your doctor's prescription for Tyzeka - Insurance information (if applicable) ### Step 2: Complete the Patient Section Fill out the patient section of the enrollment application with your personal information, including: - Full name and date of birth - Contact information (phone and address) - Household income and family size - Current insurance status - Authorization for Novartis to contact you about your medication Sign and date the form.[1] ### Step 3: Have Your Doctor Complete the Prescription Section Give the application form to your healthcare provider. Your doctor will: - Verify your diagnosis of chronic hepatitis B - Confirm the Tyzeka prescription and dosage - Certify that you meet the program's medical eligibility criteria - Sign and date the form[1] ### Step 4: Submit Your Application Mail or fax your completed application with all required financial documentation to: **Novartis Patient Assistance Foundation, Inc.** - **Mailing Address:** P.O. Box 52029, Phoenix, AZ 85072-2029 - **Phone:** 1-800-277-2254 - **Fax:** 1-855-817-2711[1] ## Timeline and Medication Delivery The program will review your application after receipt. While specific processing times are not detailed in program materials, most patient assistance programs process applications within 5-10 business days. Novartis will contact you to confirm your eligibility and arrange medication delivery. The company may also contact you directly to confirm receipt of your medications.[1] ## Insurance Requirements The Novartis Patient Assistance Foundation serves both insured and uninsured patients. If you have insurance, the program may work with your coverage or provide medication as a supplement. Discuss your insurance status with the program when you call. ## What If Your Application Is Denied If you do not qualify for the Novartis program, ask your doctor or the program about: - Other patient assistance programs for hepatitis B medications - State pharmaceutical assistance programs - Community health center resources - Generic telbivudine options, which may be more affordable[8] ## Important Reminders - Keep all appointments with your healthcare provider while taking Tyzeka - Report any unusual muscle pain, weakness, nerve problems, or signs of liver problems to your doctor immediately[6] - Do not stop taking Tyzeka without talking to your doctor first - Novartis may revise, change, or terminate this program at any time[1] ## Disclaimer This guide provides general information about the Novartis Patient Assistance Foundation program for Tyzeka. Program details, eligibility requirements, and application procedures may change. For the most current and complete information, contact the program directly at 1-800-277-2254 or visit Novartis.com. This information is not a substitute for professional medical advice. Always consult your healthcare provider about your treatment options and medication needs.

Program information last verified: March 30, 2026